Catalyst Wire Dossier Catalyst Wire Dossier

Hyftor

sirolimus · Plusultra pharma GmbH
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Hyftor, covering 2022-03-22 to 2026-08-06. Get the full timeline:

Most recent: EMA Authorised: Hyftor (sirolimus) — Plusultra pharma GmbH

See pricing